- $4.82bn
- $4.66bn
- $536.77m
- 99
- 12
- 88
- 73
2020 January 3rd | 2021 December 31st | 2021 January 1st | 2022 December 30th | 2023 December 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 417 | 466 | 400 | 513 | 537 |
Cost of Revenue | |||||
Gross Profit | 391 | 435 | 378 | 464 | 497 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 332 | 357 | 317 | 372 | 425 |
Operating Profit | 85.1 | 109 | 83.2 | 141 | 111 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 104 | 126 | 96.9 | 132 | 136 |
Provision for Income Taxes | |||||
Net Income After Taxes | 82.5 | 101 | 82.6 | 102 | 100 |
Net Income Before Extraordinary Items | |||||
Net Income | 82.5 | 101 | 82.6 | 102 | 100 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 82.5 | 101 | 82.6 | 102 | 100 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.53 | 1.9 | 1.55 | 1.96 | 1.94 |
Dividends per Share |